I2I
CVS icon

Insight 2811 Inc’s CVS Health CVS Stock Holding History

Insight 2811 Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,513
Closed -$261K – 96
2023
Q1 		$261K Sell
3,513
-138
-4% -$11.6K 0.16% 75
2022
Q4 		$340K Sell
3,651
-396
-10% -$38.2K 0.21% 62
2022
Q3 		$386K Buy
4,047
+30
+0.7% +$2.97K 0.26% 46
2022
Q2 		$372K Buy
4,017
+186
+5% +$18.2K 0.24% 47
2022
Q1 		$388K Sell
3,831
-1,806
-32% -$190K 0.23% 55
2021
Q4 		$582K Buy
5,637
+477
+9% +$44.1K 0.33% 32
2021
Q3 		$438K Sell
5,160
-863
-14% -$72.3K 0.26% 40
2021
Q2 		$503K Buy
6,023
+335
+6% +$27.4K 0.28% 41
2021
Q1 		$428K Sell
5,688
-40
-0.7% -$2.91K 0.25% 41
2020
Q4 		$391K Buy
5,728
+1,595
+39% +$104K 0.23% 45
2020
Q3 		$241K Buy
4,133
+42
+1% +$2.61K 0.15% 50
2020
Q2 		$261K Sell
4,091
-602
-13% -$37.9K 0.17% 48
2020
Q1 		$278K Sell
4,693
-2,053
-30% -$137K 0.2% 40
2019
Q4 		$501K Sell
6,746
-100
-1% -$7.02K 0.33% 42
2019
Q3 		$432K Sell
6,846
-1,042
-13% -$61.7K 0.31% 50
2019
Q2 		$435K Buy
7,888
+305
+4% +$16.4K 0.31% 53
2019
Q1 		$409K Sell
7,583
-1,124
-13% -$69.4K 0.31% 56
2018
Q4 		$570K Sell
8,707
-1,524
-15% -$114K 0.48% 39
2018
Q3 		$805K Buy
10,231
+1,700
+20% +$122K 0.54% 37
2018
Q2 		$549K Sell
8,531
-100
-1% -$6.59K 0.38% 47
2018
Q1 		$537K Sell
8,631
-900
-9% -$64.6K 0.39% 46
2017
Q4 		$691K Sell
9,531
-2,897
-23% -$211K 0.51% 41
2017
Q3 		$1.01M Buy
12,428
+7
+0.1% +$554 0.75% 17
2017
Q2 		$999K Buy
12,421
+1,200
+11% +$94.8K 0.76% 19
2017
Q1 		$881K Buy
11,221
+4,221
+60% +$337K 0.67% 30
2016
Q4 		$552K Buy
+7,000
New +$566K 0.45% 39

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Insight 2811 Inc's CVS Position: Q2 2023 in Review

Insight 2811 Inc sold out of CVS Health (CVS) in Q2 2023, closing a stake of 3,513 shares — an estimated $261K sold.

Insight 2811 Inc first reported a position in CVS in Q4 2016 and held it in 26 quarters. The position peaked at $1.01M in Q3 2017. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Insight 2811 Inc reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Insight 2811 Inc sold 3,513 CVS Health shares in Q2 2023, an estimated $261K.
  • Insight 2811 Inc first reported a position in CVS Health in Q4 2016 and held it in 26 quarters.
  • Insight 2811 Inc's CVS Health position peaked at $1.01M in Q3 2017.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Insight 2811 Inc's 13F filing for Q2 2023, filed 4 Aug 2023.